Former United States Securities and Exchange Commission attorney Willie
Briscoe, founder of The
Briscoe Law Firm, PLLC, and the securities litigation firm of Powers
Taylor LLP announce that the firms are investigating legal claims
against the officers and Board of Directors of Edwards Lifesciences
Corporation (“Edwards Lifesciences” or “Company”) (NYSE:EW) related to
potential securities violations between April 25, 2012 and April 23,
2013 (the “Class Period”).
If you are an affected investor and you want to learn more about the
lawsuit or join the action, contact Willie Briscoe at The Briscoe Law
Firm, PLLC, (214) 239-4568, or via email at WBriscoe@TheBriscoeLawFirm.com,
or Zachary Groover at Powers Taylor, LLP, toll free (877) 728-9607, via
e-mail at zach@powerstyalor.com.
There is no cost or fee to you.
In a recently filed federal class action complaint, Edwards Lifesciences
and certain of its officers and directors were charged with violating
certain provisions of the Securities Exchange Act of 1934. Specifically,
the complaint alleges that defendants’ misrepresented, among other
things, that (a) the adoption of SAPIEN was weaker than the Company
proclaimed due to concerns among physicians over the risks and
complexity of the procedure to implant the valve; (b) the Company’s
outlook for sales and earnings per share was significantly weaker than
the optimistic guidance Defendants offered to investors; and (c) as a
result of the above, the positive statements released by Defendants
regarding the Company’s operations, forecasts and outlook were
unfounded. According to the complaint, when the truth came out, the
share price of Edwards Lifesciences dropped dramatically.
“Recent revelations about alleged improper business practices and
procedures regarding key aspects of Edwards Lifesciences’ business and
other misleading financial statements have prompted the firms to
investigate possible breaches of fiduciary duties and other violations
of state law by Edwards Lifesciences’ officers and directors. Based on
our investigation, we are prepared to pursue litigation to preserve the
company and the value of Edwards Lifesciences stock for all
shareholders,” said shareholder rights attorney Willie Briscoe.
The
Briscoe Law Firm, PLLC is a full service business litigation,
commercial transaction, and public advocacy firm with more than 20 years
of experience in complex litigation and transactional matters.
Powers
Taylor, LLP is a boutique litigation law firm that handles a variety
of complex business litigation matters, including claims of investor and
stockholder fraud, shareholder oppression, shareholder derivative suits,
and security class actions.
Copyright Business Wire 2013